Non-small Cell Lung Cancer Stage IIIC
1 clinical trials · Condition
◉ Watch Non-small Cell Lung Cancer Stage IIIC
| Record | Firm | Date |
|---|---|---|
| Risk-adapted, Proteomic-guided Systemic Therapy for Previously Untreated Advanced Non-small Cell Lung Cancer (NCT07250477) | University of California, Davis | 2026-01-30 |
Track Non-small Cell Lung Cancer Stage IIIC automatically
Every clearance here is in the API, with alerts when new ones post.